US HB163 | 2009-2010 | 111th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on January 6 2009 - 25% progression, died in committee
Action: 2009-01-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 6 2009 - 25% progression, died in committee
Action: 2009-01-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Prescription Drug Affordability Act - Amends the Internal Revenue Code to allow a nonrefundable tax credit for 80 percent of the amount paid for a prescribed drug during the taxable year (and not compensated for by insurance or otherwise) by a taxpayer who has attained social security retirement age.Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to repeal provisions restricting the importation of prescription drugs. Allows a person who meets applicable legal requirements to be an importer of prescription drugs upon application to the Secretary of Health and Human Services. Requires the Secretary to approve such an application if the drug meets all FFDCA requirements for admission into the United States, including that the drug has been approved by the Food and Drug Administration (FDA) and is not adulterated or misbranded.Prohibits the Secretary from taking any action against any of the persons involved with the interstate sale of a prescription drug through an Internet site if: (1) the sale was made in compliance with FFDCA, the Controlled Substances Act, and applicable state laws; and (2) accurate information regarding compliance with such laws is posted on the Internet site.
Title
Prescription Drug Affordability Act
Sponsors
Rep. Ron Paul [R-TX] | Rep. Bennie Thompson [D-MS] |
History
Date | Chamber | Action |
---|---|---|
2009-01-14 | Referred to the Subcommittee on Health. | |
2009-01-06 | Referred to House Ways and Means | |
2009-01-06 | Referred to House Energy and Commerce | |
2009-01-06 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | |
2009-01-06 | Sponsor introductory remarks on measure. (CR E5) |
Subjects
Administrative law and regulatory procedures
Administrative remedies
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Health
Income tax credits
Internet and video services
Licensing and registrations
Prescription drugs
Trade restrictions
Administrative remedies
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Health
Income tax credits
Internet and video services
Licensing and registrations
Prescription drugs
Trade restrictions
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/111th-congress/house-bill/163/all-info |
Text | https://www.congress.gov/111/bills/hr163/BILLS-111hr163ih.pdf |